Table 2. Effect of Screening Intervention on Surrogate Endpoints (e.g., Stage at Diagnosis and Adenoma Detection)

Screening InterventionStudy DesignInternal ValidityConsistencyMagnitude of Effects on Surrogate EndpointsExternal Validity
Sigmoidoscopy [2 ,3]Case-control studies PoorFairAbout 45% decrease in detection rate of cancers compared with colonoscopyPoor
FOBT/ Sigmoidoscopy [4,5]Randomized controlled studiesFairPoorNo difference in diagnostic yield between sigmoidoscopy + FOBT vs. sigmoidoscopy aloneN/A
Barium Enema [6]Ecologic and descriptive studiesFairPoorBarium enema detects about 30%–50% of cancers detected by colonoscopyN/A
Colonoscopy [7,8]Ecologic and descriptive studiesFairPoorAbout 3% of patients with no distal adenomas have advanced proximal neoplasia. There is a threefold increase in this rate in patients with distal adenomas.N/A
CT Colonography [9 -11]Ecologic and descriptive studiesFairPoorCT colonography may have similar sensitivity to colonoscopy in certain centersPoor
Stool DNA Mutation Tests [12]Studies in progress UnknownUnknownUnknownUnknown
Immunochemical FOBTCross-sectional study in which iFOBT is administered to persons receiving colonoscopy GoodGoodiFOBT detects >60% and ≤90% of CRCsN/A

CRC = colorectal cancer; CT = computed tomography; FOBT = fecal occult blood test; iFOBT = immunochemical fecal occult blood test; N/A = not available.

From: Colorectal Cancer Screening (PDQ®)

Cover of PDQ Cancer Information Summaries
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.